Joel V Chua

University of Maryland Medical Center, Baltimore, Maryland, United States

Are you Joel V Chua?

Claim your profile

Publications (2)4.72 Total impact

  • Source
    Joel V Chua, Wilbur H Chen
    [Show abstract] [Hide abstract]
    ABSTRACT: Herpes zoster, also known as shingles, is a disease that results from the reactivation of a latent infection of the varicella zoster virus, which is usually encountered during early childhood. Aging is associated with an increased risk for herpes zoster and its complications. Boosting immunological memory is the key strategy for keeping the latent varicella zoster virus infection under control. A live attenuated virus vaccine is safe, effective and approved for use among healthy elderly adults aged 60 years or older. However, significant problems remain in the prevention of herpes zoster with the current vaccine. Future studies for improved vaccines and studies into the epidemiology of herpes zoster are required in order to address this significant public health burden.
    Aging Health 04/2010; 6(2):169-176.
  • Source
    Joel V Chua, Wilbur H Chen
    [Show abstract] [Hide abstract]
    ABSTRACT: Vaccination is the most effective means for the prevention of influenza, including pandemic strains. An ideal pandemic influenza vaccine should provide effective protection with the fewest number of doses in the shortest amount of time, and among the greatest proportion of the population. The current manufacturing processes required for embryonated chicken-egg-based influenza vaccines are limited in their ability to respond to pandemic situations - these limitations include problems with surge capacity, the need for egg-adapted strains, the possibility of contamination, and the presence of trace egg protein. Several vaccine strategies to circumvent the deficiencies intrinsic to an egg-based influenza vaccine are in various phases of development. These include the use of cell-culture-based growth systems, concomitant use of adjuvants, whole virus vaccines, recombinant protein vaccines, plasmid DNA vaccines, virus-like particle vaccines, and universal flu vaccines.
    Critical care (London, England) 01/2010; 14(2):218. · 4.72 Impact Factor

Publication Stats

6 Citations
4.72 Total Impact Points

Institutions

  • 2010
    • University of Maryland Medical Center
      • Division of Infectious Diseases
      Baltimore, Maryland, United States